Practice parameters and focusing research: Plasma exchange for myasthenia gravis

Muscle and Nerve

Volumn 43, Issue 5, 2011, Pages 625-626

  Kaminski, Henry J ^a   Cutter, Gary ^b   Ruff, Robert ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MEDICAL ETHICS; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHAM PROCEDURE; THYMECTOMY;

BIOMEDICAL RESEARCH; HUMANS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; PRACTICE GUIDELINES AS TOPIC;

EID: 79955569679     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22080     Document Type: Editorial

References (10)

1. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011;76:294-300.
2. Getchius TS, Moses LK, French J, Gronseth GS, England JD, Miyasaki J. AAN guidelines: a benefit to the neurologist. Neurology 2010;75:1126-1127.
3. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55: 7-15.
4. Newsom-Davis J, Cutter G, Wolfe GI, Kaminski HJ, Jareszki A III, Minisman G, et al. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. Ann NY Acad Sci 2008;1132:344-347.
5. Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol 2004;24:75-81.
6. Aban IB, Wolfe GI, Cutter GR, Kaminski HJ, Jareszki A III, Minisman G, et al. The MGTX experience: challenges in planning and executing an international, multicenter clinical trial. J Neuroimmunol 2008;201:80-84.
7. Strech D, Soltmann B, Weikert B, Bauer M, Pfennig A. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review. J Clin Psychiatry January 25, 2011 [Epub ahead of print].
8. Initial national priorities for comparative effectiveness research. Washington, DC: Institute of Medicine; 2009.
9. Johnston SC, Hauser SL. IOM task impossible: set the agenda for neurological comparative effectiveness research. Ann Neurol 2009;66:A4-6.
10. Miller FG, Joffe S. Equipoise and the dilemma of randomized clinical trials. N Engl J Med 2011;364:476-480.